J Clin Pharmacol
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     

Sign In to gain access to subscriptions and/or personal tools.
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Freedman, M.
Right arrow Articles by Fleisher, S
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Freedman, M.
Right arrow Articles by Fleisher, S
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Articles

Tolerance and efficacy of polyethylene glycol 3350/electrolyte solution versus lactulose in relieving opiate induced constipation: a double-blinded placebo-controlled trial

MD Freedman, HJ Schwartz, R Roby, and S Fleisher

Chronicity and high therapeutic cost prompted this study to determine a cost-effective and efficacious regimen in treating narcotic-induced constipation. The efficacy of lactulose was compared with polyethylene glycol 3350/electrolyte solution for relief of methadone-induced constipation. This was a randomized, triple cross-over after control run-in (no treatment) study conducted at a methadone maintenance program in Baltimore, Maryland in 57 patients who are affected by opiate-induced constipation. The study was measured by self-reported frequencies, consistency, and ease of defecation during a 1 week run-in control period, followed by 3 treatment phases of 2 weeks each. Polyethylene glycol 3350/electrolyte solution and lactulose produced more "nonhard" stools than the placebo (P < 0.01) and control (P < 0.003). Polyethylene glycol 3350/electrolyte solution produced the loosest stool (P < 0.0001) compared with the control, whereas lactulose had the most adverse effects. There were no significant differences in reducing hard stool formation in either experimental group, but both were better than having nothing or just the placebo. Polyethylene glycol/electrolyte solution resulted in the loosest (diarrheal) stool. It is also likely that polyethylene glycol/electrolyte solution is the most cost effective.
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?


This article has been cited by other articles:


Home page
Palliat MedHome page
P. Larkin, N. Sykes, C Centeno, J. Ellershaw, F Elsner, B Eugene, J. Gootjes, M Nabal, A Noguera, C Ripamonti, et al.
The management of constipation in palliative care: clinical practice recommendations
Palliative Medicine, October 1, 2008; 22(7): 796 - 807.
[Abstract] [PDF]


Home page
Palliat MedHome page
P. W. Keeley, E. T. Waterhouse, and S. I.R. Noble
The evidence base of palliative medicine: is inpatient palliative medicine evidence-based?
Palliative Medicine, October 1, 2007; 21(7): 623 - 627.
[Abstract] [PDF]


Home page
AM J HOSP PALLIAT CAREHome page
S. Wirz and E. Klaschik
Management of constipation in palliative care patients undergoing opioid therapy: Is polyethylene glycol an option?
American Journal of Hospice and Palliative Medicine, September 1, 2005; 22(5): 375 - 381.
[Abstract] [PDF]


Home page
Palliat MedHome page
P Good and B Stafford
Inpatient palliative medicine is evidence based
Palliative Medicine, September 1, 2001; 15(6): 493 - 498.
[Abstract] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1997 by the American College of Clinical Pharmacology